What Woodline Partners LP changed, 2019 to 2026
27 quarterly 13F filings, from Q4 2019 to Q2 2026, each read from the filing itself. A quarter is compared only with the quarter before it, so a quarter with no filing is a gap in the record, not a sale.
Reported book
$32.4bn
$2.4bn at Q4 2019
Positions
1,011
105 at Q4 2019
Top ten weight
17%
27% at Q4 2019
Typical quarterly turnover
about 38%
Estimated from share changes
- Q4 2019: $2.4bn
- Q1 2020: $1.4bn
- Q2 2020: $2.5bn
- Q3 2020: $3.1bn
- Q4 2020: $3.8bn
- Q1 2021: $4.5bn
- Q2 2021: $5.4bn
- Q3 2021: $6.1bn
- Q4 2021: $7.0bn
- Q1 2022: $6.2bn
- Q2 2022: $6.5bn
- Q3 2022: $7.2bn
- Q4 2022: $7.5bn
- Q1 2023: $7.4bn
- Q2 2023: $8.4bn
- Q3 2023: $8.5bn
- Q4 2023: $9.2bn
- Q1 2024: $10.9bn
- Q2 2024: $10.5bn
- Q3 2024: $11.9bn
- Q4 2024: $14.8bn
- Q1 2025: $15.4bn
- Q2 2025: $18.9bn
- Q3 2025: $21.2bn
- Q4 2025: $25.8bn
- Q1 2026: $26.4bn
- Q2 2026: $32.4bn
- Q4 2019: 27%
- Q1 2020: 30%
- Q2 2020: 26%
- Q3 2020: 28%
- Q4 2020: 22%
- Q1 2021: 19%
- Q2 2021: 20%
- Q3 2021: 16%
- Q4 2021: 16%
- Q1 2022: 16%
- Q2 2022: 18%
- Q3 2022: 17%
- Q4 2022: 16%
- Q1 2023: 17%
- Q2 2023: 16%
- Q3 2023: 17%
- Q4 2023: 15%
- Q1 2024: 14%
- Q2 2024: 15%
- Q3 2024: 12%
- Q4 2024: 13%
- Q1 2025: 12%
- Q2 2025: 15%
- Q3 2025: 16%
- Q4 2025: 19%
- Q1 2026: 17%
- Q2 2026: 17%
The positions that defined it
Every position that was ever among the 25 largest: when it first appeared, when it was largest, and where it stands in Q2 2026. The line is its reported value each quarter.
| Position | Value over time | First listed | Largest | Q2 2026 |
|---|---|---|---|---|
| Nvidia Corp(NVDA) | Q4 2019 | $1.1bnQ2 2026 | $1.1bn | |
| Apple Inc(AAPL) | Q1 2020 | $927mQ2 2026 | $927m | |
| Microsoft Corp(MSFT) | Q3 2021 | $630mQ4 2025 | $607m | |
| Amazon Com Inc(AMZN) | Q1 2020 | $588mQ2 2026 | $588m | |
| Facebook Inc(META)Class A | Q4 2019 | $463mQ2 2026 | $463m | |
| Broadcom Inc(AVGO) | Q1 2021 | $444mQ2 2026 | $444m | |
| Alphabet Inc(GOOGL)Capital Stock Class A | Q1 2020 | $412mQ1 2026 | $396m | |
| Revolution Medicines Inc(RVMD) | Q1 2020 | $375mQ2 2026 | $375m | |
| Alphabet Inc(GOOG)Capital Stock Class C | Q4 2024 | $362mQ2 2026 | $362m | |
| Micron Technology Inc(MU) | Q4 2019 | $317mQ2 2026 | $317m | |
| Lilly Eli & Co(LLY) | Q4 2019 | $294mQ2 2026 | $294m | |
| Tesla Inc(TSLA) | Q4 2021 | $270mQ2 2026 | $270m | |
| iShares Core S&P500 ETF(IVV) | Q4 2025 | $1.0bnQ4 2025 | Soldlast listed Q4 2025 | |
| Spdr S&P 500 Etf Trust(SPY) | Q3 2021 | $366mQ2 2022 | Soldlast listed Q1 2023 | |
| Activision Blizzard Inc | Q4 2019 | $238mQ3 2023 | Soldlast listed Q3 2023 | |
| Te Connectivity LTD | Q1 2022 | $215mQ1 2024 | Soldlast listed Q2 2024 | |
| Seagen Inc | Q4 2020 | $203mQ1 2022 | Soldlast listed Q3 2023 | |
| Ovintiv Inc(OVV) | Q3 2023 | $190mQ2 2024 | Below the listed rangelast listed Q2 2025 | |
| Travelers Companies Inc(TRV) | Q4 2024 | $163mQ4 2025 | Soldlast listed Q1 2026 | |
| Merus N V | Q4 2021 | $158mQ3 2025 | Soldlast listed Q3 2025 |
Quarter by quarter
Q3 2024: $11.9bn across 586 positions
Against Q2 2024: 203 new, 219 added to, 153 trimmed, 161 sold out, across all 586 positions.
Turnover about 34% of the book, estimated from share changes at quarter-end prices.
Largest additions
- Facebook Inc (META)+$117m
- Gilead Sciences Inc (GILD)+$93m
- Stmicroelectronics N V (STM)+$88m
- Aon PLC (AON)+$74m
- Vaxcyte Inc (PCVX)+$73m
- Intuit (INTU)+$66m
- Janux Therapeutics Inc (JANX)+$60m
- Take-two Interactive Softwar (TTWO)+$58m
Largest reductions
- Lilly Eli & Co (LLY)-$156m
- Regeneron Pharmaceuticals (REGN)-$87m
- Ovintiv Inc (OVV)-$76m
- Electronic Arts Inc (EA)-$76m
- Gallagher Arthur J & Co (AJG)-$68m
- Microsoft Corp (MSFT)-$59m
- Blueprint Medicines Corp-$53m
- Spirit Aerosystems HLDGS Inc-$48m
Opened
- Asml Holding N V (ASML)$125m
- Metlife Inc (MET)$79m
Sold out
- Te Connectivity LTDwas $161m
- Marsh & Mclennan Cos Inc (MRSH)was $123m
- Hubspot Inc (HUBS)was $64m
- Morphic HLDG Incwas $61m
- Applied Matls Inc (AMAT)was $52m
- Service Corp Intl (SCI)was $51m
- Workday Inc (WDAY)was $46m
- Humana Inc (HUM)was $44m
Largest positions, Q3 2024
The largest 25 of 586 reported positions; the largest 500 carry 99.6% of the reported value.
| Position | Value | Weight | On the quarter |
|---|---|---|---|
| Facebook Inc (META) | $242m | 2.0% | Added |
| Gilead Sciences Inc (GILD) | $162m | 1.4% | Added |
| Abbvie Inc (ABBV) | $160m | 1.3% | Added |
| Revolution Medicines Inc (RVMD) | $156m | 1.3% | Added |
| Vaxcyte Inc (PCVX) | $126m | 1.1% | Added |
| Asml Holding N V (ASML) | $125m | 1.1% | New |
| Nuvalent Inc (NUVL) | $122m | 1.0% | Added |
| Permian Resources Corp (PR) | $118m | 1.0% | Added |
| Ovintiv Inc (OVV) | $114m | 1.0% | Trimmed |
| Keysight Technologies Inc (KEYS) | $113m | 1.0% | Added |
| Danaher Corporation (DHR) | $109m | 0.9% | Added |
| Aon PLC (AON) | $107m | 0.9% | Added |
| Stmicroelectronics N V (STM) | $105m | 0.9% | Added |
| Regeneron Pharmaceuticals (REGN) | $105m | 0.9% | Trimmed |
| Eqt Corp (EQT) | $103m | 0.9% | Added |
| L3harris Technologies Inc (LHX) | $103m | 0.9% | Added |
| Gulfport Energy Corp (GPOR) | $102m | 0.9% | Added |
| Lilly Eli & Co (LLY) | $101m | 0.9% | Trimmed |
| Roivant Sciences LTD (ROIV) | $100m | 0.8% | Added |
| Amgen Inc (AMGN) | $99m | 0.8% | Added |
| Zimmer Biomet HLDGS Inc (ZBH) | $99m | 0.8% | Trimmed |
| Merck & Co. Inc (MRK) | $96m | 0.8% | Added |
| Chord Energy Corporation (CHRD) | $84m | 0.7% | Trimmed |
| Celldex Therapeutics Inc New (CLDX) | $80m | 0.7% | Added |
| Metlife Inc (MET) | $79m | 0.7% | New |
The books most like this one
Among the managers whose filings are on file, at Q2 2026. Overlap is the share of the two books that is the same: for every stock both list, the smaller of its two weights, added up. Two books can overlap because both own the largest companies; it says nothing about whether the managers agree.
| Manager | Overlap | Stocks in both | Overlap over time | |
|---|---|---|---|---|
| T. Rowe Price Associates Inc | at least 42% | 234 | Compare | |
| Wellington Management Group LLP | at least 42% | 227 | Compare | |
| Fidelity (FMR LLC) | at least 40% | 236 | Compare | |
| Invesco Ltd | at least 40% | 241 | Compare | |
| AllianceBernstein LP | at least 40% | 232 | Compare | |
| Neuberger Berman Group LLC | at least 40% | 197 | Compare | |
| Janus Henderson Group Ltd | at least 39% | 207 | Compare | |
| Acadian Asset Management LLC | at least 36% | 162 | Compare |
“At least” where either manager has more positions than are read each quarter: a stock both hold below that range is not counted.
The filings behind it
Every quarter above is one 13F holdings report, with any amendment the filer made to it applied in the order it was filed. Where the reporting entity changed, each quarter keeps the filer that actually reported it.
| Quarter | Filer | Book | Amended | Filing |
|---|---|---|---|---|
| Q2 2026 | Woodline Partners LP | $32.4bn | 13F-HR | |
| Q1 2026 | Woodline Partners LP | $26.4bn | 13F-HR | |
| Q4 2025 | Woodline Partners LP | $25.8bn | 13F-HR | |
| Q3 2025 | Woodline Partners LP | $21.2bn | 13F-HR | |
| Q2 2025 | Woodline Partners LP | $18.9bn | 13F-HR | |
| Q1 2025 | Woodline Partners LP | $15.4bn | 13F-HR | |
| Q4 2024 | Woodline Partners LP | $14.8bn | 13F-HR | |
| Q3 2024 | Woodline Partners LP | $11.9bn | 13F-HR | |
| Q2 2024 | Woodline Partners LP | $10.5bn | 13F-HR | |
| Q1 2024 | Woodline Partners LP | $10.9bn | 13F-HR | |
| Q4 2023 | Woodline Partners LP | $9.2bn | 13F-HR | |
| Q3 2023 | Woodline Partners LP | $8.5bn | 13F-HR | |
| Q2 2023 | Woodline Partners LP | $8.4bn | 13F-HR | |
| Q1 2023 | Woodline Partners LP | $7.4bn | 13F-HR | |
| Q4 2022 | Woodline Partners LP | $7.5bn | 13F-HR | |
| Q3 2022 | Woodline Partners LP | $7.2bn | 13F-HR | |
| Q2 2022 | Woodline Partners LP | $6.5bn | 13F-HR | |
| Q1 2022 | Woodline Partners LP | $6.2bn | 13F-HR | |
| Q4 2021 | Woodline Partners LP | $7.0bn | 13F-HR | |
| Q3 2021 | Woodline Partners LP | $6.1bn | 13F-HR | |
| Q2 2021 | Woodline Partners LP | $5.4bn | 13F-HR | |
| Q1 2021 | Woodline Partners LP | $4.5bn | 13F-HR | |
| Q4 2020 | Woodline Partners LP | $3.8bn | 13F-HR | |
| Q3 2020 | Woodline Partners LP | $3.1bn | 13F-HR | |
| Q2 2020 | Woodline Partners LP | $2.5bn | 13F-HR | |
| Q1 2020 | Woodline Partners LP | $1.4bn | 13F-HR | |
| Q4 2019 | Woodline Partners LP | $2.4bn | 13F-HR |
Reading this record
A 13F lists US-listed long equity and options at the quarter end, filed up to 45 days later. It shows what was held, not when it was bought or at what price, and nothing short. Where a quarter lists only the largest positions, a name missing from it may still be held below that range; the counts of what was opened and sold always cover the whole filing.
Company names, tickers and logos are the trademarks of their respective owners and appear here to identify the company whose public figures are being used. L3VLUP is not affiliated with, sponsored by or endorsed by any company shown, and nothing here is a statement by or about that company. More